Milestone Pharmaceuticals Inc. Common Shares (MIST) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Milestone Pharmaceuticals Inc. Common Shares (MIST) is Moderate Underperform.

The composite score behind that read is -0.30, weighing +0.00 of bullish evidence against -0.46 bearish.

Milestone Pharmaceuticals Inc. Common Shares last closed at $0.77, +8.45% on the session.

Against the IVW growth benchmark the position is +7.65% over the forecast window.

The read is built from 15 underlying insights — 0 bullish and 15 bearish.

Agreement across those insights is 100%.

20 graded predictions for MIST so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Milestone Pharmaceuticals Inc. Common Shares in the 3rd percentile on return on equity, where 100 is best.

Milestone Pharmaceuticals Inc. Common Shares is classified under Health Care / Pharmaceuticals, with a market capitalisation of $88.66M.

StockMap tracks Milestone Pharmaceuticals Inc. Common Shares as the 103rd largest of the 151 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 90 Neutral, 46 Moderate Underperform and 15 Moderate Outperform.

On that composite Milestone Pharmaceuticals Inc. Common Shares ranks 127th of 151 in the group, against a group median of -0.08.